Rhythm Biosciences Revamps Corporate Governance

Rhythm Biosciences Ltd. (AU:RHY) has released an update.

Rhythm Biosciences Limited has conducted a comprehensive review of its corporate governance framework, aligning with the ASX Corporate Governance Principles and Recommendations. The updated governance policies and procedures, reflecting the review outcomes, are now accessible on the company’s website. Rhythm Biosciences confirms its adherence to these governance standards in its Corporate Governance Statement for the fiscal year ending 30 June 2024.

For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.